Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial.
Li-Nong JiJinmiao LuLeili GaoChangjiang YingJiao SunJie HanWenhua ZhaoYunming GaoKun WangXin ZhengDaosheng XieJuping DingJiahong ZhaoQiang YuTong WangPublished in: Diabetes, obesity & metabolism (2023)
Cetagliptin monotherapy was effective and well tolerated in Chinese patients with T2D who had inadequate glycaemic control on exercise and diet.